During the progression of NAFLD, inflammation through the activation of nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways increases the activity of Kupffer cells and aggravates the progression of liver and systemic inflammation. This evidence concerns the gene WNK2 and metabolic dysfunction-associated steatotic liver disease.